Results of switching to milnacipran in fibromyalgia patients with an inadequate response to duloxetine: a phase IV pilot study

BACKGROUND: The purpose of this study was to evaluate the safety, tolerability, and efficacy of milnacipran following a direct switch from duloxetine in fibromyalgia patients experiencing inadequate clinical response to duloxetine after receiving treatment for 6 weeks or longer. METHODS: This explor...

Descripción completa

Detalles Bibliográficos
Autores principales: Bateman, Lucinda, Palmer, Robert H, Trugman, Joel M, Lin, Yuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643187/
https://www.ncbi.nlm.nih.gov/pubmed/23658494
http://dx.doi.org/10.2147/JPR.S43395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643187/
https://www.ncbi.nlm.nih.gov/pubmed/23658494
http://dx.doi.org/10.2147/JPR.S43395

Ejemplares similares